188 related articles for article (PubMed ID: 7488312)
1. Structure-activity relationship studies in the field of calcium antagonists. Xanthone 1,4-dihydropyridines bearing a 2,3-lactone ring.
Rampa A; Budriesi R; Bisi A; Fabbri G; Barili PL; Chiarini A; Valenti P
Arzneimittelforschung; 1995 Sep; 45(9):957-62. PubMed ID: 7488312
[TBL] [Abstract][Full Text] [Related]
2. SAR studies in the field of Ca-antagonists: 2-substituted 1,4-dihydropyridines with a xanthone backbone.
Bisi A; Budriesi R; Chiarini A; Rampa A; Valenti P
Farmaco; 1993 Nov; 48(11):1491-502. PubMed ID: 8110362
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological profile of some chloroxanthone-1, 4-dihydropyridine derivatives.
Bisi A; Budriesi R; Rampa A; Fabbri G; Chiarini A; Valenti P
Arzneimittelforschung; 1996 Sep; 46(9):848-51. PubMed ID: 8876931
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship studies of xanthone and fluorenone-1,4-dihydropyridine-5-phosphonates.
Budriesi R; Rampa A; Bisi A; Fabbri G; Chiarini A; Valenti P
Arzneimittelforschung; 1996 Apr; 46(4):374-7. PubMed ID: 8740081
[TBL] [Abstract][Full Text] [Related]
5. Fluorenone and benzophenone 1,4-dihydropyridine derivatives with cardiodepressant activity.
Rampa A; Budriesi R; Bisi A; Chiarini A; Valenti P
Arzneimittelforschung; 1992 Nov; 42(11):1284-7. PubMed ID: 1492840
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological characterization of some benzazepinone derivatives.
Budriesi R; Rampa A; Bisi A; Fabbri G; Chiarini A; Valenti P
Arzneimittelforschung; 1995 Mar; 45(3):234-9. PubMed ID: 7741775
[TBL] [Abstract][Full Text] [Related]
7. Xanthone 1,4-dihydropyridine derivatives with a potent selective bradycardic effect.
Valenti P; Chiarini A; Gasperi F; Budriesi R
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):122-5. PubMed ID: 2334451
[TBL] [Abstract][Full Text] [Related]
8. Negative inotropic and chronotropic activity of calcium channel ligands possessing a xanthone 1,4-dihydropyridine backbone.
Chiarini A; Rampa A; Bisi A; Budriesi R; Valenti P
Arzneimittelforschung; 1992 Jun; 42(6):797-801. PubMed ID: 1329778
[TBL] [Abstract][Full Text] [Related]
9. 4-heterotricyclic substituted 1,4-dihydropyridines with a potent selective bradycardic effect.
Rampa A; Chiarini A; Bisi A; Budriesi R; Valenti P
Arzneimittelforschung; 1991 Jul; 41(7):705-9. PubMed ID: 1772458
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cardiodepressant activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-(pentatomic-heteroaryl)-3,5-pyridine-dicarbo xylates. 2.
Baraldi PG; Garuti L; Leoni A; Cacciari B; Budriesi R; Chiarini A
Drug Des Discov; 1993; 10(4):319-29. PubMed ID: 8148471
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, rotamer orientation, and calcium channel modulation activities of alkyl and 2-phenethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(3- or 6-substituted-2-pyridyl)-5-pyridinecarboxylates.
Iqbal N; Akula MR; Vo D; Matowe WC; McEwen CA; Wolowyk MW; Knaus EE
J Med Chem; 1998 May; 41(11):1827-37. PubMed ID: 9599233
[TBL] [Abstract][Full Text] [Related]
13. Coumarin 1,4-dihydropyridine derivatives.
Valenti P; Rampa A; Budriesi R; Bisi A; Chiarini A
Bioorg Med Chem; 1998 Jun; 6(6):803-10. PubMed ID: 9681146
[TBL] [Abstract][Full Text] [Related]
14. Long-acting dihydropyridine calcium antagonists. 3. Synthesis and structure-activity relationships for a series of 2-[(heterocyclylmethoxy)methyl] derivatives.
Alker D; Campbell SF; Cross PE; Burges RA; Carter AJ; Gardiner DG
J Med Chem; 1989 Oct; 32(10):2381-8. PubMed ID: 2795609
[TBL] [Abstract][Full Text] [Related]
15. 1,4-Dihydropyridine derivatives as calcium channel modulators: the role of 3-methoxy-flavone moiety.
Budriesi R; Bisi A; Ioan P; Rampa A; Gobbi S; Belluti F; Piazzi L; Valenti P; Chiarini A
Bioorg Med Chem; 2005 May; 13(10):3423-30. PubMed ID: 15848754
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cardiovascular properties of furazanyl-1,4-dihydropyridines and of furoxanyl analogues.
Gasco AM; Fruttero R; Sorba G; Gasco A; Budriesi R; Chiarini A
Arzneimittelforschung; 1992 Jul; 42(7):921-5. PubMed ID: 1418057
[TBL] [Abstract][Full Text] [Related]
17. New benzoxazine and benzothiazine derivatives--structure-activity relations in guinea-pig heart and smooth muscle preparations.
Studenik C; Lemmens-Gruber R; Heistracher P
Pharmazie; 1999 May; 54(5):330-4. PubMed ID: 10368825
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of a new class of 1,4-dihydropyridines having a hydroxamic ester group in position 3 with a potential calcium antagonistic activity.
Inglesi M; Nicola M; Magnetti S
Farmaco; 1990 Dec; 45(12):1327-40. PubMed ID: 2090142
[TBL] [Abstract][Full Text] [Related]
19. In-vitro negative chronotropic and inotropic effects of a novel dihydropyridine derivative, CD-832, in the guinea-pig: comparison with calcium-channel antagonists.
Noguchi K; Takahashi K; Higuchi S
J Pharm Pharmacol; 1998 Mar; 50(3):329-34. PubMed ID: 9600727
[TBL] [Abstract][Full Text] [Related]
20. In vitro assessment for vascular selectivity of a new dihydropyridine derivative, NB-818.
Hattori Y; Fukao M; Houzen H; Qi F; Yamada Y; Kanno M
Eur J Pharmacol; 1996 Apr; 301(1-3):99-106. PubMed ID: 8773452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
